Premium
Letter: tenofovir may be superior to entecavir for treatment‐naïve chronic hepatitis B patients
Author(s) -
Wang JiGan,
Chen Rui,
Wang LiChuan
Publication year - 2021
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.16323
Subject(s) - entecavir , tenofovir , medicine , chronic hepatitis , hepatitis b , gastroenterology , virology , virus , human immunodeficiency virus (hiv) , lamivudine